These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 4936584

  • 1. Effect of antilymphocyte serum on renal allograft survival in dogs with special reference to the cytotoxic titer and immunosuppressive activity.
    Matsukura M, Sekiguchi M, Endo S, Kurosawa T, Koishi T.
    Jpn J Exp Med; 1971 Aug; 41(4):369-73. PubMed ID: 4936584
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Horse anti-dog-lymphocyte serum].
    Dormont J, Eyquem A, Lavergne M, Bach JF, Dimitriu D, Watchi JM, Lamy R, Raynaud M.
    Prog Immunobiol Stand; 1970 Aug; 4():230-8. PubMed ID: 4921387
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of antithymocyte serum in the treatment of canine renal homografts.
    Braf ZF, Smellie WA, Williams GM, Hume DM.
    Surg Gynecol Obstet; 1969 Jul; 129(1):71-8. PubMed ID: 4892857
    [No Abstract] [Full Text] [Related]

  • 5. Influence of SD and LD matching on kidney allograft survival in unrelated mongrel dogs.
    Westbroek DL, Vriesendorp HM, van den Tweel JG, de Gruyl J, van Urk H.
    Transplant Proc; 1975 Sep; 7(3):427-9. PubMed ID: 125947
    [No Abstract] [Full Text] [Related]

  • 6. The effect of adult thymectomy in dogs on the immunosuppressive activity of antilymphocyte serum (ALS).
    Mogi G, Harvey JE, Ogura JH.
    Laryngoscope; 1974 Jan; 84(1):78-83. PubMed ID: 4589567
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolonged renal allograft survival associated with antigen pretreatment.
    Wilson RE, Rippen A, Hayes CR, Dagher RK, Busch GJ.
    Transplant Proc; 1969 Mar; 1(1):290-2. PubMed ID: 4944229
    [No Abstract] [Full Text] [Related]

  • 13. [Antilymphocyte sera in experimental and clinical medicine].
    Kaden J.
    Dtsch Gesundheitsw; 1972 Feb 10; 27(6):241-7. PubMed ID: 4622789
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experience with large-dose intravenous antithymocyte globulin in primates and man.
    Cosimi AB, Skamene E, Bonney WW, Russell PS.
    Surgery; 1970 Jul 10; 68(1):54-61. PubMed ID: 4193070
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
    Shanfield I, Wolf JS, Wren SF, MacLean LD, Hume DM.
    Transplant Proc; 1973 Mar 10; 5(1):533-4. PubMed ID: 4572113
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-thymocytic globulin in canine renal allotransplantation. II. Immunosuppressive and toxic effect with subsutaneous and intravenous administration.
    Collste LG.
    Acta Chir Scand; 1972 Mar 10; 138(7):661-6. PubMed ID: 4566004
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of enriched anti-dog-lymphocyte gamma globulins].
    Kaden J, Teichmann B, Vogt R.
    Allerg Immunol (Leipz); 1973 Mar 10; 19(1):1-8. PubMed ID: 4274600
    [No Abstract] [Full Text] [Related]

  • 20. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP, Franco DJ.
    Transplant Proc; 1969 Mar 10; 1(1):474-8. PubMed ID: 4944263
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.